Nagy Habib

Last updated

Nagy Habib
Nagy Habib.jpg
Nagy Habib (2021)
Born1952
NationalityBritish, Egyptian
Occupation Surgeon
Known for Radio-frequency based surgical devices
Medical career
ProfessionLiver surgeon
Institutions Imperial College, London
Research

Nagy Habib (born 1952), is professor of hepato-biliary surgery at Imperial College, London, and is known for devising radio-frequency based liver resection devices which remove liver tumour with minimal blood loss. His work has also focused on stem cells and gene therapy.

Contents

Early life and education

Nagy Habib was born in Cairo, Egypt, 1952. [1] He trained under both Henri Bismuth  [ fr ] and the transplant surgeon Thomas Starzl. [2]

Career

His work has focused on stem cells and gene therapy. [3] He led the first clinical trial in the use of oncolytic adenoviruses for the treatment of liver cancer. [4] It was carried out by means of a locally restricted injection into the main blood vessel to the liver. [5] [6] The findings were published in 2001. [5] [6] It was found to be safe, but the second phase of the trial did not find it effective. [5] [6] In 2004, he took stem cells from a person with liver cirrhosis and injected them into their liver artery, resulting in some improvement of liver function. [7]

In 2003 he was appointed professor of hepato-biliary surgery at Imperial College, London. [8] In June 2007 he was appointed pro-rector for Commercial Affairs at Imperial. [4]

Habib developed several radio-frequency (RF) based liver resection devices. [9] [10] He devised the Habib RF device using the Habib needle, which has a modified version called the Habib 4X. [10] It removes tumour with minimal blood loss. [10] The procedure has come to be known as 'Habib's resection'. [11]

MiNA Therapeutics, a biotechnology company dealing in small activating RNA technology was co-founded by Habib and his son Robert. [12]

Awards and honours

He was awarded the Takreem award in December 2012, for his work in liver cancer and radio-frequency based liver resection. [4]

Selected publications

Articles

Books

Related Research Articles

<span class="mw-page-title-main">Hepatocellular carcinoma</span> Medical condition

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis. HCC is the third leading cause of cancer-related deaths worldwide.

Liver tumors are abnormal growth of liver cells on or in the liver. Several distinct types of tumors can develop in the liver because the liver is made up of various cell types. Liver tumors can be classified as benign (non-cancerous) or malignant (cancerous) growths. They may be discovered on medical imaging, and the diagnosis is often confirmed with liver biopsy. Signs and symptoms of liver masses vary from being asymptomatic to patients presenting with an abdominal mass, hepatomegaly, abdominal pain, jaundice, or some other liver dysfunction. Treatment varies and is highly specific to the type of liver tumor.

<span class="mw-page-title-main">Everolimus</span> Chemical compound

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants and as a targeted therapy in the treatment of renal cell cancer and other tumours.

<span class="mw-page-title-main">Viral hepatitis</span> Liver inflammation from a viral infection

Viral hepatitis is liver inflammation due to a viral infection. It may present in acute form as a recent infection with relatively rapid onset, or in chronic form, typically progressing from a long-lasting asymptomatic condition up to a decompensated hepatic disease and hepatocellular carcinoma (HCC).

<span class="mw-page-title-main">Liver disease</span> Medical condition

Liver disease, or hepatic disease, is any of many diseases of the liver. If long-lasting it is termed chronic liver disease. Although the diseases differ in detail, liver diseases often have features in common.

<span class="mw-page-title-main">Cholangiocarcinoma</span> Bile duct adenocarcinoma

Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. Light colored stool or dark urine may also occur. Other biliary tract cancers include gallbladder cancer and cancer of the ampulla of Vater.

<span class="mw-page-title-main">African iron overload</span> Iron overload disorder caused by consumption of home-brewed beer

African iron overload, also known as Bantu siderosis or dietary iron overload, is an iron overload disorder first observed among people of African descent in Southern Africa and Central Africa. Dietary iron overload is the consumption of large amount of home-brewed beer with high amount of iron content in it. Preparing beer in iron pots or drums results in high iron content. The iron content in home-brewed beer is around 46–82 mg/L, compared to 0.5 mg/L in commercial beer. Dietary overload was prevalent in both the rural and urban Black African population, with the introduction of commercial beer in urban areas, the condition has decreased. However, the condition is still common in rural areas. Until recently, studies have shown that genetics might play a role in this disorder. Combination of excess iron and functional changes in ferroportin seems to be the probable cause. This disorder can be treated with phlebotomy therapy or iron chelation therapy.

<span class="mw-page-title-main">Sorafenib</span> Chemical compound

Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.

Hepatectomy is the surgical resection of the liver. While the term is often employed for the removal of the liver from a liver transplant donor, this article will focus on partial resections of hepatic tissue and hepatoportoenterostomy.

<span class="mw-page-title-main">Liver cancer</span> Medical condition

Liver cancer is cancer that starts in the liver. Liver cancer can be primary or secondary. Liver metastasis is more common than that which starts in the liver. Liver cancer is increasing globally.

<span class="mw-page-title-main">Glypican 3</span> Protein-coding gene in the species Homo sapiens

Glypican-3 is a protein that, in humans, is encoded by the GPC3 gene. The GPC3 gene is located on human X chromosome (Xq26) where the most common gene encodes a 70-kDa core protein with 580 amino acids. Three variants have been detected that encode alternatively spliced forms termed Isoforms 1 (NP_001158089), Isoform 3 (NP_001158090) and Isoform 4 (NP_001158091).

Small activating Ribonucleic acids (saRNAs) are small double-stranded RNAs (dsRNAs) that target gene promoters to induce transcriptional gene activation in a process known as RNA activation (RNAa).

<span class="mw-page-title-main">Fibrolamellar hepatocellular carcinoma</span> Medical condition

Fibrolamellar carcinoma (FLC) is a rare form of carcinoma that typically affects young adults and is characterized, under the microscope, by laminated fibrous layers interspersed between the tumor cells. It has been estimated that 200 new cases are diagnosed worldwide each year. However, in light of recent advances in our molecular understanding, this has recently been revised to suggest it may be at least ten times more common. FLC, also known as fibrolamellar hepatocellular carcinoma, is different from the more common hepatocellular carcinoma (HCC) in that it afflicts young people with normal liver function and no known risk factors.

<span class="mw-page-title-main">Selective internal radiation therapy</span>

Selective internal radiation therapy (SIRT), also known as transarterial radioembolization (TARE), radioembolization or intra-arterial microbrachytherapy is a form of radiation therapy used in interventional radiology to treat cancer. It is generally for selected patients with surgically unresectable cancers, especially hepatocellular carcinoma or metastasis to the liver. The treatment involves injecting tiny microspheres of radioactive material into the arteries that supply the tumor, where the spheres lodge in the small vessels of the tumor. Because this treatment combines radiotherapy with embolization, it is also called radioembolization. The chemotherapeutic analogue is called chemoembolization, of which transcatheter arterial chemoembolization (TACE) is the usual form.

miR-122

miR-122 is a miRNA that is conserved among vertebrate species. miR-122 is not present in invertebrates, and no close paralogs of miR-122 have been detected. miR-122 is highly expressed in the liver, where it has been implicated as a regulator of fatty-acid metabolism in mouse studies. Reduced miR-122 levels are associated with hepatocellular carcinoma. miR-122 also plays an important positive role in the regulation of hepatitis C virus replication.

JX-594 is an oncolytic virus is designed to target and destroy cancer cells. It is also known as Pexa-Vec, INN pexastimogene devacirepvec) and was constructed in Dr. Edmund Lattime's lab at Thomas Jefferson University, tested in clinical trials on melanoma patients, and licensed and further developed by SillaJen.

Adenovirus varieties have been explored extensively as a viral vector for gene therapy and also as an oncolytic virus.

Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancer and cancer-related problems using targeted minimally invasive procedures performed under image guidance. Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.

Radiation lobectomy is a form of radiation therapy used in interventional radiology to treat liver cancer. It is performed in patients that would be surgical candidates for resection, but cannot undergo surgery due to insufficient remaining liver tissue. It consists of injecting small radioactive beads loaded with yttrium-90 into the hepatic artery feeding the hepatic lobe in which the tumor is located. This is done with the intent of inducing growth in the contralateral hepatic lobe, not dissimilarly from portal vein embolization (PVE).

<span class="mw-page-title-main">Viral vector vaccine</span> Type of vaccine

A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.

References

  1. "Habib Nagy / Curriculum Vitae". www.s466593873.onlinehome.fr. Retrieved 28 November 2021.
  2. "Interview with Nagy Habib". Oligonucleutide Therapeutic Society. 8 January 2019. Archived from the original on 29 November 2021. Retrieved 27 November 2021.
  3. Sugand, Kapil; Hills, Alexander (22 March 2008). "Professor Nagy Habib". British Medical Journal . 336 (7645): s109. doi:10.1136/bmj.39510.543056.CE. ISSN   0959-8138. S2CID   80337462.
  4. 1 2 3 "Home - Professor Nagy Habib". www.imperial.ac.uk. Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  5. 1 2 3 Doerfler, Walter; Böhm, Petra (2013). Adenoviruses: Model and Vectors in Virus-Host Interactions: Immune System, Oncogenesis, Gene Therapy. Springer. pp. 316–320. ISBN   978-3-662-05599-1.
  6. 1 2 3 Avila, M. A.; Berasain, C.; Sangro, B.; Prieto, J. (June 2006). "New therapies for hepatocellular carcinoma". Oncogene. 25 (27): 3866–3884. doi:10.1038/sj.onc.1209550. hdl: 10171/27496 . ISSN   1476-5594. PMID   6799628. S2CID   8901643.
  7. Nill, Kimball (2005). Glossary of Biotechnology Terms, Fourth Edition (4th ed.). Boca Raton: CRC Press. p. 9. ISBN   0-8493-6609-7.
  8. "Professor Nagy Habib". www.imperial.nhs.uk. Archived from the original on 29 November 2021. Retrieved 28 November 2021.
  9. Krestanova, Alice; Kracmar, Jan; Hlavackova, Milada; Kubicek, Jan; Vavra, Petr; Penhaker, Marek; Ihnat, Petr (2019). "Design and testing of radio frequency instrument RONLINE". In Pietka, Ewa; Badura, Pawel; Kawa, Jacek; Wieclawek, Wojciech (eds.). Information Technology in Biomedicine. Springer. p. 638. ISBN   978-3-030-23761-5.
  10. 1 2 3 Kumaran, Vinay (2016). "2. Techniques for transection of the liver". Techniques of Liver Surgery. New Delhi: JP Medical Ltd. p. 15. ISBN   978-93-85891-56-4.
  11. Penhaker, Marek; Vavra, Petr; Hlavackova, Mlada; Kracmar, Jan; Sikora, Tadeusz; Prokop, Lucas (2012). "Linear surgical instrument for bipolar multi electrode radiofrquency ablation". In Madarász, Ladislav; Živčák, Jozef (eds.). Aspects of Computational Intelligence: Theory and Applications: Revised and Selected Papers of the 15th IEEE International Conference on Intelligent Engineering Systems 2011, INES 2011. Springer. p. 308. ISBN   978-3-642-30668-6.
  12. Ralph, Alex (12 May 2021). "Father and son pioneers at MiNA Therapeutics clinch US pharma deal". The Times. Archived from the original on 8 December 2021. Retrieved 8 December 2021.